Patient-Centered Acupuncture for Pain (PCAP)
Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors
1 other identifier
observational
36
1 country
1
Brief Summary
The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 29, 2014
CompletedFirst Posted
Study publicly available on registry
June 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedJanuary 14, 2015
January 1, 2015
8 months
May 29, 2014
January 13, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Adverse Events
12 weeks
Study Arms (1)
Cancer survivors
Interventions
Eligibility Criteria
Cancer survivors 18 years or older with pain ratings of 4 or greater on a 0-10 numerical rating scale; primary diagnosis of cancer (stages I-III); finished primary cancer treatment; Karnofsky score 60 or greater; and who have been taking pain medications daily.
You may qualify if:
- Women or men age 18 years or older
- Primary diagnosis of cancer with history of stage I, II, or III cancer
- Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)
- Have a Karnofsky score of 60 or greater
- Can understand written English
- Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week
- Have been taking pain medications daily
- Have had at least 15 days with pain in the preceding 30 days.
You may not qualify if:
- Women or men with metastatic (stage IV) cancer
- Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks
- Planned surgical procedures in the next 12 weeks
- Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization
- Women who are pregnant or breastfeeding
- Unwillingness to adhere to study related procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Mao, MD
Abramson Cancer Center at Penn Medicine
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2014
First Posted
June 2, 2014
Study Start
May 1, 2014
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
January 14, 2015
Record last verified: 2015-01